# Abexxa Biologics, Inc. — Form D

Abexxa Biologics, Inc. of ARLINGTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-19. The offering totals $1.7M, of which $1.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-09-19
- Form: D
- Accession: 0001684213-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.7M
- Amount sold: $1.2M
- Remaining: $500K
- Investors: 3
- Date of first sale: 2016-09-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-270910

## Issuer

- Name: Abexxa Biologics, Inc.
- CIK: 0001684213
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: NANOFAB BUILDING, 500 S. COOPER ST., ARLINGTON, TX, 76019
- Phone: 512-497-5742

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Martin Heidecker | Director | Cambridge, MA |
| Debra Weidanz | Director | Arlington, TX |
| Jon Weidanz | Director | Arlington, TX |
| Debra Weidanz | Executive Officer | Arlington, TX |
| Jon Weidanz | Executive Officer | Arlington, TX |

## More

- [CIK 1684213 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1684213&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001684213-16-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.